Vial Dedicated Phase I Unit
Vial’s Dermatology Phase 1 unit provides a unified full service solution to early clinical development.
500+
Dermatology Clinical Trials
64
Phase 1 Studies
42
Indications
10,000+
Randomized Patients
Phase 1 Units are critical to advancing care and validating treatments, that’s why it’s critical to have a Phase 1 Unit that you can rely on
Janet DuBois, MD
Medical Director, CRO
Dr. DuBois has overseen more than 200 trials and is a leading Dermatology PI
Karina Garcia
Site Director
Site Director Karina Garcia manages the 15-person research-only site and oversees all Phase 1 pre-planning and execution.
Confinement, Repeat PKs, ECG, and other timed procedures by experienced staff who can handle the complexity of overlapping subjects with multiple repeat procedures
Our Phase 1 research coordinators are IATA and CPR certified with 5-25 year of experience! They are familiar with multiple EDS and IWRS systems. All research coordinators complete annual GCP and NIH training as well as in-house reucurring training.
DRI’s 7,000 sq ft clinic
- 7 exam rooms
- 2 labs
- 2 refrigerated centrifuges
- 2 commercial refrigerators for drug storage
- Dedicated photography room
- Large conference room
- Private monitoring offices with WiFi
- 350 sq.ft. secure, limited entry, temperature-controlled drug room
- Two minus 80 and three minus 20 freezers
- Extensive experience in FIH studies
- 16 dedicated beds (scale to 20)
- Full confinement capabilities
- Recreational areas, private rooms, full kitchen / showers
- Over 50 FIH/ PK studies completed
- Access to local laboratory
One-site Phase 1 Actinic Keratosis study
One-site Phase 1 study initiated in February 2020 for Actinic Keratosis. Screened 48 and randomized 32 over a four month screening/ enrollment period. Study included multiple PK days (-1, -0.5, 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10 hrs) and overnight confinement. $15k ad budget.
